National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant interleukin-12
A recombinant form of the endogenous heterodimeric cytokine interleukin-12 with potential antineoplastic activity. Recombinant interleukin-12 binds to and activates its cell-surface receptor, stimulating the production of interferon-gamma (IFN) which, in turn, induces IFN-gamma-inducible protein-10 (IP-10) and so inhibits tumor angiogenesis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:cytotoxic lymphocyte maturation factor
interleukin-12
natural killer cell stimulatory factor
recombinant human interleukin-12 (IL-12) cytokine
Abbreviation:IL-12
Code name:Ro 24-7472



Previous:recombinant interferon beta, recombinant interferon gamma, recombinant interleukin-1-alpha, recombinant interleukin-1-beta, recombinant interleukin-11
Next:recombinant interleukin-18, recombinant interleukin-3, recombinant interleukin-4, recombinant interleukin-6, recombinant interleukin-7

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov